Anna Sjögren
Chief Tech/Sci/R&D Officer at EGETIS THERAPEUTICS AB
Profile
Anna Sjögren is currently the Director-Project & Clinical Development at Egetis Therapeutics AB.
Previously, she worked as the Director-Clinical Operations at OxThera AB from 2013 to 2017.
She received her undergraduate degrees from Karolinska Institutet and the University of Uppsala.
Anna Sjögren active positions
| Companies | Position | Start |
|---|---|---|
| EGETIS THERAPEUTICS AB | Chief Tech/Sci/R&D Officer | - |
Former positions of Anna Sjögren
| Companies | Position | End |
|---|---|---|
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | 2017-11-30 |
Training of Anna Sjögren
| Karolinska Institutet | Undergraduate Degree |
| University of Uppsala | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EGETIS THERAPEUTICS AB | Health Technology |
| Private companies | 1 |
|---|---|
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Health Technology |
- Stock Market
- Insiders
- Anna Sjögren
